Skip to content
Research Article Open access CC BY 4.0

Predictors of Bleeding after Percutaneous Coronary Intervention

Kerols Safwat Ayob Esa, Ibtsam Khairat Abdelhayi, Yasser El Barbary, Mai Mohamed Salama

Cardiology and Angiology: An International Journal · pp. 154–161 · Published 11 Jul 2023

10.9734/ca/2023/v12i4354

Abstract

Background: Acute coronary syndrome patient outcomes have been improved using early invasive techniques. The aim of this study was to investigate the incidence, location, and severity of bleeding in PCI-treated cases to identify patient risk profiles and increased bleeding occurrences. Methods: This prospective observational study evaluated percutaneous coronary angiography in 80 patients with hypertension and diabetes mellitus who planned to undergo primary or elective PCI. The cases were separated into 2 groups; those who reported bleeding (n=11) and those who did not (n=69). All patients underwent physical examination, laboratory evaluation, 12-lead electrocardiography, and PCI. Results: In univariate regression analysis, age (OR: 1.09, 95% CI: 1.009 – 1.192), female gender (OR: 4.32, 95% CI: 1.157 – 16.131), history of peripheral arterial disease (OR: 7.31, 95% CI: 1.585 – 33.742), and femoral site of vascular access (OR: 9.6, 95% CI: 2.263 – 40.721) were independent predictors of major bleeding after PCI. In multivariate regression analysis, age (OR: 1.12, 95% CI:1.014 – 1.269), female gender (OR: 13.75, 95% CI: 1.983 – 161.2), history of peripheral arterial disease (OR: 43.38, 95% CI: 3.754 - 1042) and femoral site of vascular access (OR: 13.29, 95% CI: 2.233 – 128.5) were independent predictors of major bleeding after PCI. Conclusions: Patients who reported bleeding after PCI had a significantly higher age, prevalence of female sex, serum creatinine, and transfemoral intervention before and after intervention compared to patients who did not report bleeding, while haemoglobin and transradial intervention before and after intervention were significantly lower in the bleeding cases than in the non-bleeding cases.

Acute coronary syndrome bleeding percutaneous coronary intervention

References (23)

  1. 1 Clinical End Points in Coronary Stent Trials [DOI]
  2. 2 Bivalirudin for Patients with Acute Coronary Syndromes [DOI]
  3. 3 Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study [DOI]
  4. 4 Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention [DOI]
  5. 5 Assessment of the SYNTAX score in the Syntax study [DOI]
  6. 6 Incidence, Predictors, and Impact of Post-Discharge Bleeding After Percutaneous Coronary Intervention [DOI]
  7. 7 Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: Study design and rationale [DOI]
  8. 8 Incidence, predictors, and clinical impact of bleeding after transradial coronary stenting and maximal antiplatelet therapy [DOI]
  9. 9 Access and Non–Access Site Bleeding After Percutaneous Coronary Intervention and Risk of Subsequent Mortality and Major Adverse Cardiovascular Events [DOI]
  10. 10 Complex PCI procedures: challenges for the interventional cardiologist [DOI]
  11. 11 Major Adverse Cardiovascular Events: An Inevitable Outcome of ST-elevation myocardial infarction? A Literature Review [DOI]
  12. 12 Outcomes of Women and Men With Acute Coronary Syndrome Treated With and Without Percutaneous Coronary Revascularization [DOI]
  13. 13 Incidence and predictors of bleeding complications after percutaneous coronary intervention [DOI]
  14. 14 Postdischarge Bleeding After Percutaneous Coronary Intervention and Subsequent Mortality and Myocardial Infarction [DOI]
  15. 15 Weight of the bleeding impact on early and late mortality after percutaneous coronary intervention [DOI]
  16. 16 Advanced liver disease: what every hepatitis C virus treater should know.
  17. 17 Access and non-access site bleeding after percutaneous coronary intervention and risk of subsequent mortality and major adverse cardiovascular events: A systematic review and meta-analysis
  18. 18 Association between arterial access site and anticoagulation strategy on major bleeding and mortality: A historical cohort analysis in the Veteran population [DOI]
  19. 19 Predicting long‐term bleeding after percutaneous coronary intervention [DOI]
  20. 20 Blood transfusion after percutaneous coronary intervention and risk of subsequent adverse outcomes: A systematic review and meta-analysis [DOI]
  21. 21 Bleeding Severity in Percutaneous Coronary Intervention (PCI) and its Impact on Short-Term Clinical Outcomes [DOI]
  22. 22 Major bleeding events in Jordanian patients undergoing percutaneous coronary intervention (PCI): Incidence, associated factors, impact on prognosis, and predictability of the CRUSADE bleeding risk score. Results from the First Jordanian PCR (PCR1) [DOI]
  23. 23 [Advanced chronic kidney disease].

Cited by 0

No indexed citations yet.

Related research

Article metrics

Real usage data collected on this platform.

93

Page views

0

PDF downloads

39

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.